Evaluation of the effects of protease-digested lyophilized powder of bee larvae on dizziness.

Not Applicable

• Conditions: Patient with dizziness

• Registration Number: JPRN-UMIN000028327
• Lead Sponsor: Kawagoe Otology Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2018-09-04
• Study Start: 2019-03-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

[1] Individuals with acute vertigo (meniere's syndrome, benign paroxysmal positional vertigo, vestibular neuritis and so on) [2] Individuals with dizziness and vertigo caused by severe desease (cerebral infarction, intracranial hemorrhage, brain tumor and so on). [3] Individuals who have a severe allergy or asthma. [4] Heavy smoker or alcoholism. [5] Individuals whose dietary habit is excessively irregular. [6] Individuals who usually take bee larvae. [7] Individuals who have an infection needed systemic therapy. [8] Individuals who are considered that participation for this trial is difficult because of psychiatric symptoms or psychosis. [9] Individuals who have a kidney disease. [10] Individuals judged inappropriate for participating the study by the principal

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dizziness Handicap Inventory (DHI) (at a few weeks and 1 day before the intervention, and after 4, 8, 12, 16 weeks of daily intake.)

Secondary Outcome Measures

Name	Time	Method
Frenzel eye movement measurement, stabilometry, the measurement with autonomic nervous system (at 1 day before the intervention, and after 4, 8, 12, 16 weeks of daily intake.)